{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:24:37Z","timestamp":1783038277356,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Clinical and Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["2020-I2M-2-009"],"award-info":[{"award-number":["2020-I2M-2-009"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901667"],"award-info":[{"award-number":["81901667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071841"],"award-info":[{"award-number":["82071841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2019 Discipline Development Project of Peking Union Medical College","award":["201920200106"],"award-info":[{"award-number":["201920200106"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gorham\u2013Stout syndrome (GSS) is a rare disorder with various presentations and unpredictable prognoses. Previous understandings of GSS mainly focused on progressive bone destruction, while we identified a group of GSS patients with serous effusion as the first symptom. This study aimed to investigate the clinical characteristics of patients with GSS having serous effusion as the first symptom.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients diagnosed with GSS were identified through the Peking Union Medical College Hospital Medical Record System. The demographic, clinical, laboratory, and imaging data were collected. Patients who first presented with serous effusion were recruited into the serous group, while those with bone destruction were recruited into the bone group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 23 patients with GSS enrolled, 13 were in the bone group and 10 in the serous group. The median disease duration was shorter and exercise tolerance was lower in the serous group. Despite less frequent bone pain in the serous group, the frequency of bone involvement was similar to that in the bone group. Patients in the serous group had higher rates of bilateral pleural effusion and multiple serous effusion. However, serous effusion also developed with disease progression in the bone group. Of the 17 patients treated with bisphosphonates, 14 reached bone-stable state. However, 5 out of 10 patients with serous effusion still had refractory effusions after bisphosphonates treatment. Three patients received sirolimus treatment, with an improvement in serous effusion. Seventeen patients were followed up; three patients died, two in the bone group and one in the serous group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study discovered that GSS could first be presented with serous effusion. We believe that this may be a new phenotype of the disease. Sirolimus might help in controlling serous effusion and improving prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-022-02307-8","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:04:08Z","timestamp":1649059448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Refractory serositis in Gorham\u2013Stout syndrome"],"prefix":"10.1186","volume":"17","author":[{"given":"Hong","family":"Di","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-0647","authenticated-orcid":false,"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"2307_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1056\/NEJM183807110182305","volume":"18","author":"JBS Jackson","year":"1838","unstructured":"Jackson JBS. A boneless arm. Boston Med Surg J. 1838;18:368\u20139.","journal-title":"Boston Med Surg J"},{"key":"2307_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2106\/00004623-195537050-00008","volume":"37","author":"LW Gorham","year":"1955","unstructured":"Gorham LW, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am. 1955;37:985\u20131004.","journal-title":"J Bone Joint Surg Am"},{"issue":"11","key":"2307_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1084\/jem.20021244","volume":"196","author":"JA Nagy","year":"2002","unstructured":"Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, et al. Vascular permeability factor\/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med. 2002;196(11):1497\u2013506.","journal-title":"J Exp Med"},{"issue":"2","key":"2307_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ydbio.2008.04.024","volume":"319","author":"M Dellinger","year":"2008","unstructured":"Dellinger M, Hunter R, Bernas M, Gale N, Yancopoulos G, Erickson R, Witte M. Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol. 2008;319(2):309\u201320.","journal-title":"Dev Biol"},{"issue":"12","key":"2307_CR5","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1182\/blood-2004-08-3382","volume":"105","author":"T Morisada","year":"2005","unstructured":"Morisada T, Oike Y, Yamada Y, Urano T, Akao M, Kubota Y, Maekawa H, Kimura Y, Ohmura M, Miyamoto T, et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood. 2005;105(12):4649\u201356.","journal-title":"Blood"},{"issue":"12","key":"2307_CR6","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1182\/blood-2004-08-3327","volume":"105","author":"T Tammela","year":"2005","unstructured":"Tammela T, Saaristo A, Lohela M, Morisada T, Tornberg J, Norrmen C, Oike Y, Pajusola K, Thurston G, Suda T, et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood. 2005;105(12):4642\u20138.","journal-title":"Blood"},{"issue":"5","key":"2307_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/path.989","volume":"195","author":"T Hirayama","year":"2001","unstructured":"Hirayama T, Sabokbar A, Itonaga I, Watt-Smith S, Athanasou NA. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham\u2013Stout disease. J Pathol. 2001;195(5):624\u201330.","journal-title":"J Pathol"},{"issue":"2","key":"2307_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1359\/JBMR.041113","volume":"20","author":"F Hammer","year":"2005","unstructured":"Hammer F, Kenn W, Wesselmann U, Hofbauer LC, Delling G, Allolio B, Arlt W. Gorham\u2013Stout disease\u2013stabilization during bisphosphonate treatment. J Bone Miner Res. 2005;20(2):350\u20133.","journal-title":"J Bone Miner Res"},{"key":"2307_CR9","doi-asserted-by":"publisher","first-page":"115068","DOI":"10.1016\/j.bone.2019.115068","volume":"130","author":"M Rossi","year":"2020","unstructured":"Rossi M, Buonuomo PS, Battafarano G, Conforti A, Mariani E, Algeri M, Pelle S, D\u2019Agostini M, Macchiaiolo M, De Vito R, et al. Dissecting the mechanisms of bone loss in Gorham\u2013Stout disease. Bone. 2020;130:115068.","journal-title":"Bone"},{"key":"2307_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s002920050341","volume":"20","author":"HGG M\u00f6ller","year":"1999","unstructured":"M\u00f6ller HGG, Priemel M, Werner M, Kuhlmey AS, Delling G. Gorham\u2013Stout idiopathic osteolysis\u2014A local osteoclastic hyperactivity? Pathologe. 1999;20:177\u201382.","journal-title":"Pathologe"},{"key":"2307_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0030-4220(83)90185-8","volume":"55","author":"HCD Leslie Heflez","year":"1983","unstructured":"Leslie Heflez HCD, Barbara L, Carter, Feeney JE. Perspectives on massive osteolysis report of a case and review of the literature. Oral Surg Oral Med Oral Pathol. 1983;55:331\u201343.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"9094","key":"2307_CR12","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/S0140-6736(05)63639-2","volume":"350","author":"H Hagberg","year":"1997","unstructured":"Hagberg H, Lamberg K, \u00c5str\u00f6m G. \u03b1-2b interferon and oral clodronate for Gorham\u2019s disease. Lancet. 1997;350(9094):1822\u20133.","journal-title":"Lancet"},{"issue":"18","key":"2307_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/01.BRS.0000084557.38858.85","volume":"28","author":"HCD Leslie Heflez","year":"2003","unstructured":"Leslie Heflez HCD, Carter BL, Feeney JE. Gorham disease of the cervical spine\u2014a case report and review of the literature. Spine. 2003;28(18):355\u20138.","journal-title":"Spine."},{"issue":"2","key":"2307_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3121\/cmr.3.2.65","volume":"3","author":"V Dipak","year":"2005","unstructured":"Dipak V, Patel M. Gorham\u2019s disease or massive osteolysis. Clin Med Res. 2005;3(2):65\u201374.","journal-title":"Clin Med Res"},{"key":"2307_CR15","unstructured":"International Society for the Study of Vascular Anomalies: ISSVA classification for Vascular Anomalies. 2018."},{"key":"2307_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bone.2014.02.011","volume":"63","author":"MT Dellinger","year":"2014","unstructured":"Dellinger MT, Garg N, Olsen BR. Viewpoints on vessels and vanishing bones in Gorham\u2013Stout disease. Bone. 2014;63:47\u201352.","journal-title":"Bone"},{"issue":"1","key":"2307_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1378\/chest.105.1.208","volume":"105","author":"ML Tie","year":"1994","unstructured":"Tie ML, Poland GA, Rosenow EC 3rd. Chylothorax in Gorham\u2019s syndrome. A common complication of a rare disease. Chest. 1994;105(1):208\u201313.","journal-title":"Chest"},{"issue":"1","key":"2307_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2003","unstructured":"Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2003;5(1):74\u201380.","journal-title":"Nat Immunol"},{"key":"2307_CR19","doi-asserted-by":"publisher","first-page":"12677","DOI":"10.1073\/pnas.221449198","volume":"98","author":"MJSA Karkkainen","year":"2001","unstructured":"Karkkainen MJSA, Jussila L, Karila KA, Lawrence EC. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci. 2001;98:12677\u201382.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"2307_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","volume":"21","author":"M Lohela","year":"2009","unstructured":"Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009;21(2):154\u201365.","journal-title":"Curr Opin Cell Biol"},{"issue":"11","key":"2307_CR21","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/j.1651-2227.2011.02361.x","volume":"100","author":"N Brodszki","year":"2011","unstructured":"Brodszki N, Lansberg JK, Dictor M, Gyllstedt E, Ewers SB, Larsson MK, Eklund EA. A novel treatment approach for paediatric Gorham\u2013Stout syndrome with chylothorax. Acta Paediatr. 2011;100(11):1448\u201353.","journal-title":"Acta Paediatr"},{"issue":"9","key":"2307_CR22","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ijporl.2013.06.004","volume":"77","author":"N Morimoto","year":"2013","unstructured":"Morimoto N, Ogiwara H, Miyazaki O, Kitamuara M, Nishina S, Nakazawa A, Maekawa T, Morota N. Gorham\u2013Stout syndrome affecting the temporal bone with cerebrospinal fluid leakage. Int J Pediatr Otorhinolaryngol. 2013;77(9):1596\u2013600.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"7","key":"2307_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00256-012-1565-4","volume":"42","author":"S Lala","year":"2013","unstructured":"Lala S, Mulliken JB, Alomari AI, Fishman SJ, Kozakewich HP, Chaudry G. Gorham\u2013Stout disease and generalized lymphatic anomaly\u2013clinical, radiologic, and histologic differentiation. Skeletal Radiol. 2013;42(7):917\u201324.","journal-title":"Skeletal Radiol"},{"key":"2307_CR24","first-page":"398","volume":"39","author":"GSB Tilling","year":"1968","unstructured":"Tilling GSB. Disappearing bone disease, morbus Gorham. Report of a case. J Clin Endocrinol Metab. 1968;39:398\u2013406.","journal-title":"J Clin Endocrinol Metab"},{"key":"2307_CR25","first-page":"1893","volume":"81","author":"RD Devlin","year":"1996","unstructured":"Devlin RD, Bone HG 3rd, Roodman GD. Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab. 1996;81:1893\u20137.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2307_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1359\/JBMR.051019","volume":"21","author":"S Colucci","year":"2006","unstructured":"Colucci S, Taraboletti G, Primo L, Viale A, Roca C, Valdembri D, Geuna M, Pagano M, Grano M, Pogrel AM, et al. Gorham\u2013Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res. 2006;21(2):207\u201318.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2307_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.bone.2009.11.015","volume":"46","author":"JL Dupond","year":"2010","unstructured":"Dupond JL, Bermont L, Runge M, de Billy M. Plasma VEGF determination in disseminated lymphangiomatosis-Gorham\u2013Stout syndrome: A marker of activity? A case report with a 5-year follow-up. Bone. 2010;46(3):873\u20136.","journal-title":"Bone"},{"key":"2307_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2106\/00004623-197759010-00009","volume":"59","author":"GKL Heyden","year":"1977","unstructured":"Heyden GKL, Nielsen JM. Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am. 1977;59:57\u201361.","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"2307_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1089\/wound.2018.0850","volume":"8","author":"M Ozeki","year":"2019","unstructured":"Ozeki M, Fukao T. Generalized lymphatic anomaly and Gorham\u2013Stout disease: overview and recent insights. Adv Wound Care (New Rochelle). 2019;8(6):230\u201345.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"1","key":"2307_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0268355520946211","volume":"36","author":"YY Han","year":"2021","unstructured":"Han YY, Sun LM, Yuan SM. Localized intravascular coagulation in venous malformations: a system review. Phlebology. 2021;36(1):38\u201342.","journal-title":"Phlebology"},{"key":"2307_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fped.2017.00158","volume":"5","author":"TA Nakano","year":"2017","unstructured":"Nakano TA, Zeinati C. Venous thromboembolism in pediatric vascular anomalies. Front Pediatr. 2017;5:158.","journal-title":"Front Pediatr"},{"issue":"1","key":"2307_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13023-021-01895-1","volume":"16","author":"G Hou","year":"2021","unstructured":"Hou G, Jiang Y, Xu W, Zhu Z, Huo L, Chen X, Li F, Xu KF, Cheng W. (68)Ga-NOTA-Evans Blue PET\/CT findings in lymphangioleiomyomatosis compared with (99\u2009m)TC-ASC lymphoscintigraphy: a prospective study. Orphanet J Rare Dis. 2021;16(1):279.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2307_CR33","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s00259-020-04685-2","volume":"47","author":"G Hou","year":"2020","unstructured":"Hou G, Xu W, Jiang Y, Xu KF, Chen X, Li F, Cheng W. Lymphangioleiomyomatosis revealed by (68)Ga-NOTA-Evans Blue PET\/CT. Eur J Nucl Med Mol Imaging. 2020;47(10):2469\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2307_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10067-014-2780-2","volume":"35","author":"Y Liu","year":"2016","unstructured":"Liu Y, Zhong DR, Zhou PR, Lv F, Ma DD, Xia WB, Jiang Y, Wang O, Xing XP, Li M. Gorham\u2013Stout disease: radiological, histological, and clinical features of 12 cases and review of literature. Clin Rheumatol. 2016;35(3):813\u201323.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2307_CR35","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1097\/RHU.0000000000001009","volume":"26","author":"C Elera-Fitzcarrald","year":"2020","unstructured":"Elera-Fitzcarrald C, Ugarte-Gil MF. Gorham\u2013Stout syndrome: a phantom bone disease treated with bisphosphonates. J Clin Rheumatol. 2020;26(5):e135-6.","journal-title":"J Clin Rheumatol"},{"issue":"8","key":"2307_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1631\/jzus.B1200308","volume":"14","author":"P Hu","year":"2013","unstructured":"Hu P, Yuan XG, Hu XY, Shen FR, Wang JA. Gorham\u2013Stout syndrome in mainland China: a case series of 67 patients and review of the literature. J Zhejiang Univ Sci B. 2013;14(8):729\u201335.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"5","key":"2307_CR37","doi-asserted-by":"publisher","first-page":"e27614","DOI":"10.1002\/pbc.27614","volume":"66","author":"KW Ricci","year":"2019","unstructured":"Ricci KW, Hammill AM, Mobberley-Schuman P, Nelson SC, Blatt J, Bender JLG, McCuaig CC, Synakiewicz A, Frieden IJ, Adams DM. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham\u2013Stout disease. Pediatr Blood Cancer. 2019;66(5):e27614.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2307_CR38","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jvsv.2021.03.001","volume":"9","author":"M Geeurickx","year":"2021","unstructured":"Geeurickx M, Labarque V. A narrative review of the role of sirolimus in the treatment of congenital vascular malformations. J Vasc Surg Venous Lymphat Disord. 2021;9(5):1321\u201333.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"2307_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2015-4450","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CR, Hammill AM. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137:1\u201310.","journal-title":"Pediatrics."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02307-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02307-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02307-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:10:26Z","timestamp":1649059826000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02307-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2307"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02307-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1294834\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Declaration of Helsinki and was approved by the Ethics Committee of Peking Union Medical College Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}